Celltrion
068270.KS
#858
Rank
NZ$46.75 B
Marketcap
NZ$213.70
Share price
-1.57%
Change (1 day)
-0.06%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2025 (TTM): NZ$3.22

According to Celltrion 's latest financial reports the company's current EPS (TTM) is NZ$3.28. In 2023 the company made an earnings per share (EPS) of NZ$4.79 a decrease over its 2022 EPS that were of NZ$4.89.

EPS history for Celltrion from 2007 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$3.22
2023NZ$4.79-2.08%
2022NZ$4.89-11.72%
2021NZ$5.542.03%
2020NZ$5.4382.8%
2019NZ$2.9718.31%
2018NZ$2.51-36.33%
2017NZ$3.95161.25%
2016NZ$1.512.86%
2015NZ$1.4717.84%
2014NZ$1.255.87%
2013NZ$1.18-70.85%
2012NZ$4.04134.09%
2011NZ$1.7243.59%
2010NZ$1.2074.49%
2009NZ$0.69317.8%
2008NZ$0.16-71.7%
2007NZ$0.58